These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35378156)

  • 1. Functionalized nanoparticles for brain targeted BDNF gene therapy to rescue Alzheimer's disease pathology in transgenic mouse model.
    Arora S; Kanekiyo T; Singh J
    Int J Biol Macromol; 2022 May; 208():901-911. PubMed ID: 35378156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased brain-derived neurotrophic factor depends on amyloid aggregation state in transgenic mouse models of Alzheimer's disease.
    Peng S; Garzon DJ; Marchese M; Klein W; Ginsberg SD; Francis BM; Mount HT; Mufson EJ; Salehi A; Fahnestock M
    J Neurosci; 2009 Jul; 29(29):9321-9. PubMed ID: 19625522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lamotrigine attenuates deficits in synaptic plasticity and accumulation of amyloid plaques in APP/PS1 transgenic mice.
    Zhang MY; Zheng CY; Zou MM; Zhu JW; Zhang Y; Wang J; Liu CF; Li QF; Xiao ZC; Li S; Ma QH; Xu RX
    Neurobiol Aging; 2014 Dec; 35(12):2713-2725. PubMed ID: 25044076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro validation of effects of BDNF-expressing mesenchymal stem cells on neurodegeneration in primary cultured neurons of APP/PS1 mice.
    Song MS; Learman CR; Ahn KC; Baker GB; Kippe J; Field EM; Dunbar GL
    Neuroscience; 2015 Oct; 307():37-50. PubMed ID: 26297896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nerve Growth Factor Gene Delivery across the Blood-Brain Barrier to Reduce Beta Amyloid Accumulation in AD Mice.
    Rodrigues BDS; Kanekiyo T; Singh J
    Mol Pharm; 2020 Jun; 17(6):2054-2063. PubMed ID: 32315185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GLUT-1: An Effective Target To Deliver Brain-Derived Neurotrophic Factor Gene Across the Blood Brain Barrier.
    Arora S; Sharma D; Singh J
    ACS Chem Neurosci; 2020 Jun; 11(11):1620-1633. PubMed ID: 32352752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
    Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
    Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of BDNF cleavage by plasminogen-activator inhibitor-1 contributes to Alzheimer's neuropathology and cognitive deficits.
    Gerenu G; Martisova E; Ferrero H; Carracedo M; Rantamäki T; Ramirez MJ; Gil-Bea FJ
    Biochim Biophys Acta Mol Basis Dis; 2017 Apr; 1863(4):991-1001. PubMed ID: 28132883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of brain-derived neurotrophic factor in plaque-associated glial cells of aged APP23 transgenic mice.
    Burbach GJ; Hellweg R; Haas CA; Del Turco D; Deicke U; Abramowski D; Jucker M; Staufenbiel M; Deller T
    J Neurosci; 2004 Mar; 24(10):2421-30. PubMed ID: 15014117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABCA7 Deficiency Accelerates Amyloid-β Generation and Alzheimer's Neuronal Pathology.
    Sakae N; Liu CC; Shinohara M; Frisch-Daiello J; Ma L; Yamazaki Y; Tachibana M; Younkin L; Kurti A; Carrasquillo MM; Zou F; Sevlever D; Bisceglio G; Gan M; Fol R; Knight P; Wang M; Han X; Fryer JD; Fitzgerald ML; Ohyagi Y; Younkin SG; Bu G; Kanekiyo T
    J Neurosci; 2016 Mar; 36(13):3848-59. PubMed ID: 27030769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
    Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
    Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and Validation of Liposomal ApoE2 Gene Delivery System to Evade Blood-Brain Barrier for Effective Treatment of Alzheimer's Disease.
    Arora S; Layek B; Singh J
    Mol Pharm; 2021 Feb; 18(2):714-725. PubMed ID: 32787268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene therapy for Alzheimer's disease targeting CD33 reduces amyloid beta accumulation and neuroinflammation.
    Griciuc A; Federico AN; Natasan J; Forte AM; McGinty D; Nguyen H; Volak A; LeRoy S; Gandhi S; Lerner EP; Hudry E; Tanzi RE; Maguire CA
    Hum Mol Genet; 2020 Oct; 29(17):2920-2935. PubMed ID: 32803224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early BDNF treatment ameliorates cell loss in the entorhinal cortex of APP transgenic mice.
    Nagahara AH; Mateling M; Kovacs I; Wang L; Eggert S; Rockenstein E; Koo EH; Masliah E; Tuszynski MH
    J Neurosci; 2013 Sep; 33(39):15596-602. PubMed ID: 24068826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD8
    Unger MS; Li E; Scharnagl L; Poupardin R; Altendorfer B; Mrowetz H; Hutter-Paier B; Weiger TM; Heneka MT; Attems J; Aigner L
    Brain Behav Immun; 2020 Oct; 89():67-86. PubMed ID: 32479993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exercise and BDNF reduce Aβ production by enhancing α-secretase processing of APP.
    Nigam SM; Xu S; Kritikou JS; Marosi K; Brodin L; Mattson MP
    J Neurochem; 2017 Jul; 142(2):286-296. PubMed ID: 28382744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of Bdnf gene deficiency to the memory impairment and brain pathology of APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Rantamäki T; Kemppainen S; Autio H; Stavén S; Koivisto H; Kojima M; Antila H; Miettinen PO; Kärkkäinen E; Karpova N; Vesa L; Lindemann L; Hoener MC; Tanila H; Castrén E
    PLoS One; 2013; 8(7):e68722. PubMed ID: 23844236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain-Derived Neurotrophic Factor in Alzheimer's Disease: Risk, Mechanisms, and Therapy.
    Song JH; Yu JT; Tan L
    Mol Neurobiol; 2015 Dec; 52(3):1477-1493. PubMed ID: 25354497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain Amyloidosis and BDNF Deficiency Have Opposite Effects on Brain Volumes in AβPP/PS1 Mice Both in vivo and ex vivo.
    Kärkkäinen E; Lahtinen HM; Närväinen J; Gröhn O; Tanila H
    J Alzheimers Dis; 2015; 46(4):929-46. PubMed ID: 26402627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective role of MMP-9 overexpression in the brain of Alzheimer's 5xFAD mice.
    Fragkouli A; Tsilibary EC; Tzinia AK
    Neurobiol Dis; 2014 Oct; 70():179-89. PubMed ID: 25008761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.